4th Quarter - Report

PRIME THERAPEUTICS for PRIME THERAPEUTICS

Firm
Client
Income
—
Expenses
$110,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Implementation of S. 2003 of the SUPPORT Act of Patients and Communities Act, provisions related to the implementation of Every Prescription Conveyed Securely Act. Presidential Executive Order on lowering Prices for Patients by Eliminating Kickbacks to Middlemen, issued July 24, 2020 requiring the completion of rulemaking to exclude from safe harbor protection drug rebates in Medicare Part D; and, Final Rule, Department of Health and Human Services: Office of Inspector General, issued November 20, 2020 entitled Fraud and Abuse; Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Services Fees. Presidential Executive Order on Lowering Drug Prices by Putting America First, Issued Sept 13, 2020 creating a Most Favored Nation Price for drugs in Medicare Part D. Outreach on pharmacy direct and indirect remuneration in Medicare Part D. H.R.19: Lower Cost, More Cures Act, provisions on drug prices and Part D cost-sharing. H.R.3: Elijah E. Cummings Lower Drug Costs Act Now, provisions establishing drug pricing and Part D cost sharing.

LobbyistCovered position, as disclosed
JULIE CAROL CANTOR-WEINBERG —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS)

Bills named: S. 2003 (116th), H.R. 19 (116th), H.R. 3 (116th)

Health Issues HCR

S.1895: The Lower Health Care Costs Act, Sec. 306, Health Plan Oversight of PBMs. H.R.133: Consolidated Appropriations Act, 2021, provisions related to PBM transparency and disclosure. H.R.19: Lower Cost, More Cures Act, provisions on drug prices and Part D cost-sharing. H.R.3: Elijah E. Cummings Lower Drug Costs Act Now, provisions establishing drug pricing and Part D cost sharing.

LobbyistCovered position, as disclosed
JULIE CAROL CANTOR-WEINBERG —

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE

Bills named: H.R. 3 (116th), H.R. 19 (116th), H.R. 133 (116th), S. 1895 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.